FDA Recalls Vasostrict Injection for Exceeding Potency Specifications
Par Sterile Products recalled Vasostrict (vasopressin) injection because stability testing showed the drug exceeded its upper potency specification limit. The recall involves 1,721 cartons distributed nationwide.
- Product
- VASOSTRICT — VASOSTRICT (VASOPRESSIN)
- Category
- Drug
- Distribution
- Distributed nationwide